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Abstract
Although the transcription factors IRF-3 and IRF-7 are considered master regulators of type I interferon (IFN) induction and
IFN stimulated gene (ISG) expression, Irf32/26Irf72/2 double knockout (DKO) myeloid dendritic cells (mDC) produce
relatively normal levels of IFN-b after viral infection. We generated Irf32/26Irf52/26Irf72/2 triple knockout (TKO) mice to
test whether IRF-5 was the source of the residual induction of IFN-b and ISGs in mDCs. In pathogenesis studies with two
unrelated positive-sense RNA viruses (West Nile virus (WNV) and murine norovirus), TKO mice succumbed at rates greater
than DKO mice and equal to or approaching those of mice lacking the type I IFN receptor (Ifnar2/2). In ex vivo studies, after
WNV infection or exposure to Toll-like receptor agonists, TKO mDCs failed to produce IFN-b or express ISGs. In contrast, this
response was sustained in TKO macrophages following WNV infection. To define IRF-regulated gene signatures, we
performed microarray analysis on WNV-infected mDC from wild type (WT), DKO, TKO, or Ifnar2/2 mice, as well as from mice
lacking the RIG-I like receptor adaptor protein MAVS. Whereas the gene induction pattern in DKO mDC was similar to WT
cells, remarkably, almost no ISG induction was detected in TKO or Mavs2/2 mDC. The relative equivalence of TKO and
Mavs2/2 responses suggested that MAVS dominantly regulates ISG induction in mDC. Moreover, we showed that MAVS-
dependent induction of ISGs can occur through an IRF-5-dependent yet IRF-3 and IRF-7-independent pathway. Our results
establish IRF-3, -5, and -7 as the key transcription factors responsible for mediating the type I IFN and ISG response in mDC
during WNV infection and suggest a novel signaling link between MAVS and IRF-5.
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Introduction
The type I interferon (IFN) signaling network is an essential
component of the innate immune response against viral infections,
and also functions to shape adaptive immunity [1–4]. Infected cells
initiate an antiviral response upon recognition of non-self
pathogen-associated molecular patterns (PAMPs), which are
detected by host pattern recognition receptors (PRRs) [2,5–8].
PRRs that recognize RNA viruses include members of the Toll-
like receptor (TLR3 and TLR7) and the RIG-I-like receptor
(RLR; RIG-I and MDA5) families. TLRs and RLRs recognize
distinct PAMPs in different locations (extracellular/endosomes
and cytoplasm, respectively) and activate signaling cascades to
initiate antiviral and inflammatory responses. TLR3 binds to
double-stranded RNA and recruits the adaptor molecule TRIF to
activate the kinases TRAF and IKK-e, which in turn activates the
latent transcription factors IRF-3, IRF-7, and NF-kB. Single-
stranded RNA is recognized by TLR7, which uses the adaptor
molecule MyD88 to activate TRAF and IKK-e, and subsequently
NF-kB- and IRF-7-dependent transcription. RLRs interact with
the mitochondria-associated adapter molecule MAVS (also called
IPS-1, VISA, or CARDIF), which signals through the kinases
TBK1 and IKK-e to activate IRF-3, IRF-7, and NF-kB and
initiate type I IFN production.
A canonical model for type I IFN production after RNA virus
infection is a two-step positive feedback loop that is regulated by
IRF-3 and IRF-7 [9,10]. In the first phase, viral sensing by TLRs
or RLRs induces nuclear localization of IRF-3, which in concert
with NF-kB and ATF-2/c-Jun stimulates transcription, synthesis,
and secretion of IFN-b and IFN-a4 by infected cells. In the second
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phase, extracellular IFN-b and IFN-a4 bind to the type I IFN
receptor (IFNAR), which triggers activation of the JAK-STAT
signaling pathway and induction of IFN-stimulated genes (ISGs)
[11]. ISGs act by a variety of mechanisms to render cells resistant
to viral replication [12,13]. Although type I IFN signaling is
required to activate the full antiviral response, a subset of ISGs is
induced directly by IRF-3 [14,15]. While IRF-3 is constitutively
expressed in many tissues, IRF-7 is an ISG required for the
expression of most IFN-a subtypes, and thus a key mediator of the
type I IFN amplification loop [2,9,10]. Certain cells, including
plasmacytoid dendritic cells and macrophages, express IRF-7
constitutively, which makes them poised for rapid IFN-a
production [16–20].
West Nile virus (WNV) is a mosquito-transmitted, enveloped,
positive-sense RNA virus and member of the Flaviviridae family.
Studies in mice with targeted gene deletions have provided insight
into mechanisms of innate immune restriction of WNV infection.
The type I IFN response is essential to the control of WNV
infection, as mice that are defective at producing or responding to
IFN cannot control virus replication and succumb rapidly to
infection [17,21–25]. The host antiviral response in vivo is
dependent upon both TLR and RLR signaling, as deficiencies
in TLRs, RLRs, or their downstream adaptor molecules (including
MyD88 and MAVS) result in enhanced viral replication and
lethality [8,22,26–30].
Recent studies with WNV have suggested that some cell types
use non-canonical signaling pathways to induce type I IFN
responses. The combined absence of IRF-3 and IRF-7 resulted in
uncontrolled WNV replication and more rapid death in
Irf32/26Irf72/2 double knockout (DKO) mice compared to the
individual single gene knockout mice [17,21,22,31]. However,
even without IRF-3 or IRF-7, type I IFN was produced by DKO
mice infected with WNV or murine cytomegalovirus, albeit at
reduced levels compared to wild type mice [22,32]. Consistent
with the sustained production of type I IFN, lethality in DKO
mice infected with WNV or chikungunya virus was not as rapid or
complete as in Ifnar2/2 mice [22,31,33,34]. Ex vivo experiments
with primary myeloid dendritic cells (mDC) and macrophages
revealed that the IFN-b response after WNV infection was
sustained in DKO cells but abrogated in the absence of MAVS
[22,27]. In contrast, the IFN-b response in neurons and fibroblasts
was abolished in the absence of either IRF-3 and IRF-7 or MAVS
[22,27]. These studies suggested cell type-specific requirements for
the transcription factors that induce IFN-b expression in response
to WNV infection.
To define the transcription factor(s) responsible for the IRF-3
and IRF-7-independent production of IFN-b in myeloid cells, we
considered another member of the IRF family, IRF-5. Although
IRF-5 was originally identified as an inducer of inflammatory
cytokines (IL-6 and TNF-a) downstream of TLR-7 and MyD88
signaling, subsequent studies suggested that it could contribute to
type I IFN production after viral infection [35–37]. In response to
Newcastle disease virus (NDV) infection, IRF-5 induced overlap-
ping and distinct sets of genes compared to IRF-7, including
stronger induction of IFN-b and the antiviral gene Rsad2 (Viperin)
[38]. We generated Irf32/26Irf52/26Irf72/2 triple knockout
(TKO) mice and found that these mice were highly vulnerable to
infection with WNV. The combined loss of IRF-3, IRF-5, and
IRF-7 largely abrogated type I IFN and ISG expression in mDC,
and microarray analysis of WNV-infected mDC revealed a set of
genes induced in DKO but not in TKO cells. Because the limited
set of genes induced in WNV-infected TKO mDCs was absent in
Mavs2/2 mDCs, we conclude that the RLR-MAVS signaling
pathway dominantly regulates innate immune gene induction in
mDCs during WNV infection, and that IRF-3, IRF-5, and IRF-7
coordinately mediate this response. Our results establish a new
linkage between the IRF-5 and the RLR signaling pathways in
induction of the antiviral IFN response.
Results
TKO mice are highly vulnerable to viral infections
We hypothesized that IRF-5 might be responsible for the
residual IFN-b production in DKO mice, because IRF-5
contributes to Ifnb mRNA expression downstream of the PRR
TLR7 and adaptor molecule MyD88, both of which limit WNV
pathogenesis in vivo [28,30,39]. To test this, we generated
Irf32/26Irf52/26Irf72/2 TKO mice (Figure S1) and defined
their response to viral infection. TKO mice were viable, fertile,
and produced progeny according to normal Mendelian frequen-
cies (data not shown). We infected WT, DKO, and TKO mice
with a virulent WNV strain (New York 2000, WNV-NY) and
found that TKO mice succumbed to infection earlier than DKO
mice (mean time to death (MTD): 4.0 days versus 5.7, P,0.0001).
TKO mice died marginally later than Ifnar2/2 mice, which do not
respond to type I IFN and fail to control WNV replication (MTD:
4.0 days versus 3.7, P,0.05) (Figure 1A) [25,31]. Because TKO,
DKO and Ifnar2/2 mice all succumbed so rapidly to WNV-NY
infection, it was difficult to appreciate biologically meaningful
differences in susceptibility among the three genotypes. To address
this, we infected these mice with an attenuated WNV strain
(Madagascar 1978, WNV-MAD) that inefficiently antagonizes
JAK/STAT signaling [23]. With this virus, we observed a
pronounced increase in mortality of TKO compared to DKO
mice (Figure 1B). Whereas 100% of TKO mice succumbed to
WNV-MAD infection, only 20% of DKO mice died (P,0.001).
TKO mice were equally vulnerable to WNV-MAD infection as
Ifnar2/2 mice (P.0.05), and no statistical difference in MTD was
observed (9.0 days for TKO versus 8.2 days for Ifnar2/2 mice,
P.0.05). Similar results were observed upon infection with murine
norovirus (MNV), an unrelated non-enveloped positive-sense
RNA virus. TKO mice were more vulnerable to MNV infection
than DKO mice, with only 1 of 11 TKO mice surviving,
Author Summary
Host pathogen sensors, including those of the Toll-like
receptor and RIG-I like receptor (RLR) families, detect viral
infection in cells. Signaling through these receptors
triggers expression of type I interferon (IFN) and IFN-
stimulated genes (ISGs), in part through the IRF family of
transcription factors. Previous studies with West Nile virus
(WNV) showed that IRF-3 and IRF-7 control IFN expression
in fibroblasts and neurons, whereas macrophages and
myeloid dendritic cells (mDC) retained the ability to induce
IFN-b without IRF-3 and IRF-7. In the current study, we
generated Irf32/26Irf52/26Irf72/2 (TKO) mice to charac-
terize the contributions of specific IRF transcription factors
to IFN and ISG induction in response to WNV infection in
cells and in mice. We found that induction of IFN and ISGs
was largely abolished in TKO mDC, but sustained in TKO
macrophages. Because IFN and ISG induction also was
absent in mDC lacking MAVS, a key mediator of RLR
signaling, our results suggest a novel signaling link
between IRF-5 and MAVS. This study establishes the
molecular pathways responsible for IFN induction in mDC
and suggests a cross-talk between IRF-5 and RLR signaling
pathways.
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compared to 100% survival for DKO mice (P,0.0001)
(Figure 1C). However, the TKO mice did not show the same
susceptibility as Ifnar2/2 mice (P,0.0001), and the MTD was
greater in TKO compared to Ifnar2/2 mice (7.8 days versus 5.3
days, P,0.001). The observation that lethality in TKO mice more
closely matched that of Ifnar2/2 mice after WNV infection
compared to MNV suggests that there may be virus-specific
differences in the particular transcription factors responsible for
mediating the antiviral response. Overall, the loss of IRF-5 in the
setting of an IRF-3 and IRF-7 deficiency renders mice more
vulnerable to viral infection and early death, approaching that
seen in mice that cannot respond to type I IFN.
To understand the basis of the increased susceptibility of TKO
mice to viral infection, we infected WT, DKO, TKO, and
Ifnar2/2 mice with WNV-NY or WNV-MAD and measured viral
burden in the draining lymph node, serum, spleen and brain at 2
days (WNV-NY) or 6 days (WNV-MAD) after infection
(Figure 1D–G). Viral infection in TKO mice was similar to that
observed in Ifnar2/2 mice (P.0.05) in all tissues examined, except
for the spleen after WNV-MAD infection where titers in TKO
mice were greater than in Ifnar2/2 mice (25-fold, P,0.05). After
infection with WNV-NY, TKO mice had higher viral loads than
DKO mice in the draining lymph node (13-fold, P,0.01), spleen
(5-fold, P,0.01), and brain (9-fold, P,0.05). After infection with
WNV-MAD, TKO mice had higher viral loads than DKO mice
in the serum (124-fold, P,0.01) and spleen (169-fold, P,0.01).
Serum antiviral activity
To determine whether the enhanced vulnerability of TKO mice
was due to an inability to generate a systemic antiviral response,
we measured type I IFN levels in the serum of mice infected with
WNV-NY (2 days after infection) or WNV-MAD (6 days after
infection) (Figure 2). Unexpectedly, we detected type I IFN
activity in the serum of TKO mice infected with WNV-NY or
WNV-MAD, and the amount present was not different from
DKO mice (P.0.05). While the serum levels of type I IFN in
Figure 1. Lethality and viral burden after virus infection. A–C. WT, Irf32/26Irf72/2 DKO, Irf32/26Irf52/26Irf72/2 TKO, and Ifnar2/2 mice were
infected subcutaneously with 102 PFU of a virulent (WNV-NY) or an attenuated (WNV-MAD) WNV strain or infected orally with 36107 PFU of MNV and
followed for lethality for 21 days (8 to 20 mice per group). DKO and Ifnar2/2 survival curves were compared to TKO by the log-rank test; asterisks
indicate survival curves that are significantly different (****, P,0.0001; ***, P,0.001; *, P,0.05). D–G. The indicated groups of mice were infected
subcutaneously with WNV-NY or WNV-MAD and tissues were harvested for viral burden analysis at 2 (WNV-NY) or 6 (WNV-MAD) days after infection.
Viral infection in the draining lymph node and serum was determined by qRT-PCR, and infection in the spleen and brain was determined by plaque
assay. Data are expressed as the mean viral titer 6 standard error of the mean (SEM) of 5 to 9 mice per group and the dotted line represents the limit
of detection of the assay. DKO and Ifnar2/2 groups were compared to TKO by the Mann-Whitney test; asterisks indicate differences that are
statistically significant (****, P,0.0001; ***, P,0.001; **, P,0.01; *, P,0.05).
doi:10.1371/journal.ppat.1003118.g001
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TKO and DKO mice were diminished compared to WT mice
after WNV-NY infection and equivalent to WT after WNV-MAD
infection, substantially higher levels of type I IFN were detected in
the serum from Ifnar2/2 mice (29-fold after WNV-NY infection,
P,0.01; 416-fold after WNV-MAD infection, P,0.0001). The
high level of type I IFN in Ifnar2/2 mice likely is a result of high
viral replication in the absence of IFN-mediated antiviral effector
functions combined with the absence of IFNAR molecules to bind
and internalize type I IFN in the serum. Despite the combined
absence of IRF-3, IRF-5, and IRF-7, TKO mice still produced
type I IFN after WNV infection, albeit at lower levels in the
context of markedly enhanced infection.
Virus control and ISG induction is ablated in TKO mDC
but not macrophages
Myeloid cells retain the ability to produce IFN-b during WNV
infection despite the lack of IRF-3 and IRF-7 [22]. To determine if
this IFN-dependent antiviral activity was mediated by IRF-5, we
performed multi-step growth analyses with WNV-NY in primary
mDC and macrophages derived from WT, DKO, TKO, and
Ifnar2/2 mice (Figure 3A and B). Viral replication in TKO
mDC was greater than in DKO mDC (74-fold, P,0.0001) and
equivalent to Ifnar2/2 mDC (P.0.05), suggesting that IRF-3, IRF-
5, and IRF-7 regulate innate immune defense to control WNV
replication in mDC. In comparison, TKO macrophages showed
little increase in WNV-NY replication compared to DKO cells,
and reached lower (11-fold, P,0.0001) peak titers compared to
Ifnar2/2 macrophages. This suggests that macrophages can
restrict WNV-NY infection through an alternative pathway that
is independent of IRF-3, IRF-5, and IRF-7, possibly through IRF-
1 and/or other transcription factors [40].
To establish whether the disparate ability of TKO mDC and
macrophages to control WNV-NY replication was associated with
differences in antiviral gene induction, we infected cells and
performed western blots to assay expression of ISGs, specifically
RIG-I (DDX58), MDA5 (IFIH1), STAT1, IFIT2 (ISG54) and
IFIT3 (ISG49) (Figure 3C and D). In TKO mDCs, we did not
detect expression of any of the tested ISGs, although these were
highly expressed in WNV-infected WT and DKO mDC
(Figure 3C and [22]). In contrast, most of these proteins were
induced in TKO macrophages, although their expression was
delayed compared to WT cells: ISG expression was detected in
TKO macrophages at only 48 hours after infection, whereas
expression was detected in WT cells within 12 hours of infection.
Unlike other ISGs, IFIT3 was not expressed in TKO macro-
phages even at 48 hours after infection, despite being induced in
DKO macrophages [22]. The lack of virus-induced ISG
expression in TKO mDC resembled the phenotype observed in
cells lacking the RLR-signaling adaptor, MAVS [27].
To further define the ISGs expressed in an IRF-3, IRF-5, or
IRF-7 dependent manner, we infected mDC and macrophages
from WT, DKO, TKO, and Ifnar2/2 mice with WNV-NY and
measured the induction of Ifnb, Oas1a, Rsad2, and Cxcl10 mRNA at
24 hours after infection by quantitative reverse transcription
polymerase chain reaction (qRT-PCR) (Figure 3E and F).
These genes were selected as known representatives of different
ISG induction pathways. Rsad2 and Cxcl10 can be induced directly
by PRR signaling and IRF-3 mediated transcriptional regulation,
whereas expression of Oas1a depends more strictly upon IFN-b
signaling [14,15,20]. Consistent with the western blot results, all
four genes were induced strongly in WT and DKO mDC, but not
in TKO mDC. In contrast, TKO macrophages retained the
ability to express Ifnb and the tested ISGs, although the level of
gene induction was equivalent to or less than WT cells, even in the
context of enhanced viral replication. As expected, Oas1a was not
induced in Ifnar2/2 cells, although these cells expressed high levels
of Rsad2, Cxcl10 and Ifnb. ISG expression in Ifnar2/2 macrophages
was especially high, likely secondary to increased viral replication
and IRF-3-dependent gene induction.
TKO mDC respond to IFN-b treatment but not to PRR
stimulation
Since TKO mDC failed to induce expression of selected ISGs in
response to WNV-NY infection, we tested their capacity to express
ISGs in response to other inflammatory stimuli including IFN-b
and the PRR agonists poly(I:C) and lipopolysaccharide (LPS)
(Figure 4). Although TKO mDC failed to induce Ifnb expression
after WNV-NY infection, they retained the ability to respond to its
signaling, inducing WT levels of Ifnb, Oas1a, Rsad2, and Cxcl10 at
24 hours after IFN-b treatment. However, these cells showed an
ablated response to poly(I:C) or LPS, with no induction of Ifnb or
the tested ISGs. Thus, TKO mDC are defective in transmitting
MyD88- and TRIF-dependent signals after PAMP sensing,
whereas the JAK/STAT-ISGF3 signaling pathway remains intact.
As observed previously, although DKO mDC induced a WT-like
pattern of ISGs after WNV infection, they had a diminished
response to stimulation by the TLR4 ligand LPS or by poly(I:C),
which is recognized by TLR3 and MDA5 [22]. This suggests that
WNV infection activates a broader range of PRRs than poly(I:C)
or LPS treatment alone.
Microarray analysis reveals a MAVS-dependent signal
through IRF-5 in mDCs
Analysis of selected ISGs in TKO mDC infected with WNV-
NY suggested a profound loss of gene induction, results that also
were seen previously in Mavs2/2 cells [27]. To evaluate this in
greater detail, we performed a microarray analysis to profile gene
Figure 2. Type I IFN activity in serum. WT, Irf32/26Irf72/2 DKO,
Irf32/26Irf52/26Irf72/2 TKO, and Ifnar2/2 mice were infected with
102 PFU of WNV-NY or WNV-MAD and serum levels of type I IFN were
measured 2 (WNV-NY) or 6 (WNV-MAD) days after infection using a
bioassay. Data represent the mean 6 SEM of 5 to 9 mice per group.
DKO and Ifnar2/2 groups were compared to TKO by a two-way ANOVA;
asterisks indicate differences that are statistically significant (****,
P,0.0001).
doi:10.1371/journal.ppat.1003118.g002
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expression patterns in TKO and Mavs2/2 mDC 24 hours after
WNV-NY infection at a multiplicity of infection (MOI) of 25. To
identify the specific contributions of IRF-5 and type I IFN
signaling to the transcriptional response, studies also were
performed with WT, DKO, and Ifnar2/2 mDCs. The level of
WNV infection of the cells used for the microarray was assessed by
flow cytometry using an anti-WNV monoclonal antibody
(Figure 5A). TKO and Mavs2/2 mDC had significantly higher
rates of infection compared to WT cells (P,0.05 and P,0.01,
respectively), whereas infection of DKO and Ifnar2/2 mDC
surprisingly was not different than WT (P.0.05). Nonetheless, for
all genotypes tested, only a fraction (up to 15%) of cells stained
Figure 3. ISG and IFN-b induction in primary myeloid cells in response to WNV infection. Primary myeloid cells from WT, Irf32/26Irf72/2
DKO, Irf32/26Irf52/26Irf72/2 TKO, and Ifnar2/2 mice were infected with WNV-NY. A and B. Bone marrow-derived mDC (A) and macrophages (B)
were infected at an MOI of 0.001 (mDC) or 0.01 (macrophages), and viral replication was measured by focus-forming assay. Data represent the mean
6 SEM of two independent experiments performed in triplicate. The dotted line represents the limit of detection of the assay. C and D: WT and TKO
mDCs (C) and macrophages (D) were infected at an MOI of 1 or mock-infected (M). At 12, 24, or 48 hours after infection, cells were lysed, separated
by SDS-PAGE and analyzed by western blot to detect expression of specific ISGs or viral proteins. One representative experiment of three is shown. E
and F: mDCs (E) and macrophages (F) were infected with WNV at an MOI of 0.1, RNA was isolated at 24 hours after infection, and relative expression
of the indicated target genes was measured by qRT-PCR. Gene expression was normalized to Gapdh and is displayed as the fold increase compared to
uninfected cells on a log2 scale. Data represent the average of three independent experiments and are expressed as the mean 6 SEM. A–B and E–F:
DKO and Ifnar2/2 groups were compared to TKO by two-way ANOVA; asterisks indicate differences that are statistically significant (****, P,0.0001;
***, P,0.001; **, P,0.01).
doi:10.1371/journal.ppat.1003118.g003
IRF-3, -5, and -7 Mediate the IFN Response in mDC
PLOS Pathogens | www.plospathogens.org 5 January 2013 | Volume 9 | Issue 1 | e1003118
positive for WNV antigen at 24 hours after infection, suggesting
that uninfected cells contributed substantially to the gene
induction profile observed in this experiment.
Gene induction was measured by comparing WNV-infected
samples to mock-infected cells of the same genotype, to control for
differential basal expression of some genes. We considered genes to
be expressed differentially in response to WNV infection if they
exhibited a fold change of $1.5 and a P-value,0.05. WNV-
infected WT mDCs showed a broad transcriptional response,
particularly of genes that are induced by PRR and type I IFN
signaling. 445 genes were expressed differentially in WNV-infected
mDC compared to mock-infected cells (Table S1). The 50 most
upregulated genes (Figure 5B) included ISGs with previously
described antiviral activity (Rsad2, Ifit2, Ifit3, Isg15, Isg20, and
Parp12) [13,41–43], members of the 29-59-oligoadenylate synthe-
tase family (Oas1g, Oas2, Oasl1, and Oasl2) [12,44,45], components
of the PRR/type I IFN (Ddx58, Dhx58, Ifnb1, Ifna2, Irf7, Stat1, and
Stat2) and ISG15 (Isg15, Ube2l6, Usp8) [12] pathways, as well as
nucleotide metabolism factors (Cmpk2 and Nt5c3). The particular
genes upregulated in DKO mDC were similar to those in WT
cells, although the magnitude of induction was lower in DKO
cells, consistent with previous observations [22]. In contrast, a
restricted set of 22 genes was expressed differentially in WNV-
infected Ifnar2/2 mDCs (Figure 5B and Table S2). Remarkably
few genes were expressed differentially in either TKO or Mavs2/2
mDC upon WNV-NY infection, suggesting that the RLR
signaling pathway is critical for initiating the type I IFN and
antiviral responses in this cell type.
To validate the results of the microarray analysis, we performed
qRT-PCR with the same RNA samples that were used for
transcriptional profiling (Figure 5C) and measured the expression
of Cxcl10, Rsad2, Ifit2, Ifnb, Ddx58, Ccl5, Ifitm3, and Ccl2. The
induction pattern measured by qRT-PCR corroborated the
microarray results. These eight genes (listed above in order of
relative expression level) were induced in WT and DKO cells but
not in TKO or Mavs2/2 cells. Consistent with the patterns
observed by microarray, Cxcl10, Rsad2, Ifit2, Ifnb, and Ccl5 were
induced in Ifnar2/2 cells (i.e., are IFN-independent), whereas
Ddx58, Ifitm3, and Ccl2 were not (i.e., are IFN-dependent). Ifit1
(ISG56) is an ISG that is highly upregulated upon WNV infection
[17,21,27,46–49], thus its absence from the infection-induced
bioset was unexpected. Upon further analysis by qRT-PCR, we
found that Ifit1 was induced to high levels in infected WT, DKO,
and Ifnar2/2 mDC but not TKO or Mavs2/2 cells. This quality
control assessment reveals that the single Ifit1 probe on our
microarray chip was defective, and that Ifit1 expression is induced
in Ifnar2/2 cells after WNV infection.
To identify genes whose expression was dependent strictly upon
IRF-5 and MAVS, we considered those upregulated in WT but
not in Mavs2/2 cells (MAVS-dependent) or in WT and DKO but
not in TKO cells (IRF-5 dependent). Since TKO and Mavs2/2
mDC failed to produce IFN-b in response to WNV infection
(Figure 3 and [27]), we stratified our analysis to consider only
genes that were upregulated in Ifnar2/2 mDC, so as to exclude
those whose differential expression might be secondary to the lack
of IFN signaling in Mavs2/2 and TKO cells. The IFN-
independent set of genes (Figure 6A and Table S2 and S3)
included Ifnb1, Rsad2, Isg15, Cxcl10, Ifit2, and Ifit3, all of which are
induced by IRF-3 without a requirement for IFNAR-mediated
signaling [14,15]. Further analysis revealed that IFN-independent
genes included cytokines (Ifnb1, Tnf, Il6), chemokines (Cxcl10, Ccl5,
Ccrl2), antiviral restriction factors (Rsad2, Isg15, Ifit2, Ifit3), and
components of the unfolded protein response (Ppp1r15a
(GADD34), Ddit3 (CHOP, GADD153), Chac1). To corroborate
this analysis, we measured the expression of Trib3, Ddit3, Ppp1r15a,
Rgs1, Nfkbiz, and Chac1 by qRT-PCR using the same RNA
samples used for the microarray (Figure 6B). We confirmed that
three of these genes were upregulated in WNV-infected TKO
mDC (Trib3, Ddit3, and Gadd45a) (Figure 6C). The qRT-PCR
data did however, yield some differences: (a) Trib3 induction was
not detected in Mavs2/2 mDC by qRT-PCR; (b) Ddit3 was
upregulated in a MAVS-independent manner; (c) Rgs1 and Nfkbiz
were not upregulated in TKO cells; (d) while Ppp1r15a was
upregulated in Ifnar2/2 mDC, it also was induced in DKO mDC;
and (e) by qRT-PCR we failed to detect expression of Chac1 in
mock- or WNV-infected mDC of any genotype, although it was
induced in WNV-infected cortical neurons (data not shown).
The absence of gene induction in TKO mDC compared to
DKO cells could reflect a direct role for IRF-5 in ISG induction or
an indirect effect of the loss of IFN-b production in TKO mDC.
Figure 4. ISG induction by IFN-b and TLR agonists in WT and deficient mDC. mDC from WT, Irf32/26Irf72/2 DKO, Irf32/26Irf52/26Irf72/2
TKO, and Ifnar2/2 mice were treated with IFN-b (500 IU/ml) (A), poly(I:C) (50 mg/ml) (B), or LPS (5 mg/ml) (C). Total RNA was isolated 24 hours later
and relative gene expression was measured by qRT-PCR. Gene expression was normalized to Gapdh and is displayed as the fold increase compared to
untreated cells on a log2 scale. Data represent the average of three independent experiments and are expressed as the mean 6 SEM. DKO and
Ifnar2/2 groups were compared to TKO by two-way ANOVA; asterisks indicate differences that are statistically significant (****, P,0.0001;
***, P,0.001; **, P,0.01; *, P,0.05).
doi:10.1371/journal.ppat.1003118.g004
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Figure 5. Microarray analysis of WNV infected mDC. mDC from WT, Irf32/26Irf72/2 DKO, Irf32/26Irf52/26Irf72/2 TKO, Mavs2/2 and Ifnar2/2
mice were infected with WNV-NY at an MOI of 25 and total RNA was harvested 24 hours later. A. WNV infection of mDC from the indicated
genotypes as assessed by anti-WNV MAb staining at 24 hours after infection. B. Heatmap showing the 50 genes with the greatest fold change in
expression in WNV-infected mDC compared to mock-infected cells, according to the indicated color scale. The gray portion of the color scale, labeled
‘‘ns’’ for non-significant, represents genes that failed to meet the cutoff criteria for induction. Gene expression was assessed by microarray analysis on
Illumina chips. Each column represents the mean of three independent samples per genotype. C. Quantitative RT-PCR was performed on the same
RNA samples analyzed by microarray to detect expression of the indicated target genes. Gene expression was normalized to Gapdh and is displayed
as the fold increase compared to mock-infected cells on a log2 scale. Data represent the average of three independent samples and are expressed as
the mean 6 SEM. The dotted line indicates a 1.5-fold increase in expression.
doi:10.1371/journal.ppat.1003118.g005
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Figure 6. Type I IFN signaling mediates gene induction by IRF-5 and MAVS. A. Heatmap displaying 22 genes induced upon WNV infection
in Ifnar2/2 mDC (greater than 1.5 fold upregulated compared to mock-infected cells, P,0.05). B. Expression of selected IFN-independent genes was
validated by qRT-PCR using the same RNA samples analyzed by microarray. Gene expression was normalized to Gapdh and is displayed as the fold
increase compared to mock-infected cells on a log2 scale. Data represent the average of three independent samples and are expressed as the mean
6 SEM. The dotted line indicates a 1.5-fold increase in expression. C. Venn diagram of the expression patterns of IFN-independent genes, based on
microarray and qRT-PCR analyses. D. DKO mDC were treated with 25 mg/ml of an IFNAR-blocking antibody (MAR1-5A3) or an isotype control
antibody (GIR-208) for one hour prior to infection with WNV-NY at an MOI of 0.1. Total RNA was isolated after 24 hours and relative gene expression
was measured by qRT-PCR. Expression of the indicated target genes was normalized to Gapdh and is displayed as the fold increase compared to
untreated cells on a log2 scale. Data represent the average of four samples from two independent experiments and are expressed as the mean 6
SEM. E. mDC from WT, Irf52/2, and DKO mice were infected with WNV-NY at an MOI of 0.1 and qRT-PCR was performed as in panel D. Data represent
the average of 12 samples from four independent experiments, are displayed as the fold increase compared to untreated cells on a log2 scale, and are
expressed as the mean 6 SEM. F. mDC from WT, Irf52/2, DKO, and TKO mice were infected with SeV at an MOI of 3 and qRT-PCR was performed as in
panel D. Data represent the average of six samples from two independent experiments, are displayed as the fold increase compared to untreated
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To test this, we inhibited type I IFN signaling in DKO cells using
an IFNAR-blocking monoclonal antibody (MAR1-5A3, [50]) and
used qRT-PCR to measure gene induction in response to WNV-
NY infection (Figure 6D). As expected, the IFNAR-blocking
antibody prevented induction of Oas1a, a known IFN-dependent
ISG [15], but did not impair induction of Ifnb. Ccl5 and Tnf were
induced too weakly to observe differences between the IFNAR-
blocking and control MAbs. However, the IFNAR-blocking
antibody abolished induction of Cxcl10, Rsad2, Ifit1, and Ifit2,
even though these genes are considered to be IFN-independent
[14,15] and were induced in Ifnar2/2 mDC (Figure 5C).
Collectively, these results suggest that IRF-5 contributes to the
induction of IFN-b expression after WNV infection in mDC, but
does not induce ISG expression directly. To further define the
contribution of IRF-5 to IFN and ISG induction in mDC, we
infected WT, Irf52/2, and DKO mDC with WNV (Figure 6E)
and WT, Irf52/2, DKO, and TKO cells with Sendai virus (SeV),
a negative sense RNA paramyxovirus (Figure 6F) and measured
gene expression by qRT-PCR. We found no change in the
induction of Ifnb, Oas1a, Rsad2, or Cxcl10 in Irf52/2 mDC
compared to WT cells (P.0.05), indicating that loss of IRF-5
alone in mDCs is not sufficient to impact the antiviral response,
analogous to results seen with IRF-3 [21]. Consistent with this
observation, we observed no significant difference in WNV-NY
replication between Irf52/2 and WT mDC (P.0.05) (Figure 6G).
Although DKO mDC retained intact IFN and ISG responses after
WNV infection, this pattern surprisingly was not observed
following SeV infection: the induced expression of several ISGs
(Oas1a, Rsad2, and Cxcl10) was lost in both DKO and TKO mDC.
While our results with DKO and TKO cells after WNV infection
establish that IRF-5 contributes to the type I IFN response in
mDCs, the critical nature of the IFN induction pathways in these
key sentinel cells may have resulted in the maintenance of
redundant signaling pathways to sustain antiviral gene programs.
Indeed, the distinct ISG induction phenotypes after WNV and
SeV infection in DKO and TKO mDCs suggest that activation of
these parallel pathways may differ among diverse viruses.
The similar gene induction profiles observed between TKO and
Mavs2/2 mDC by microarray and qRT-PCR suggested a
functional interaction between IRF-5 and MAVS. To test this
hypothesis, we transfected WT, DKO, and TKO immortalized
mouse embryonic fibroblasts (MEFs) with plasmids encoding myc-
tagged forms of a constitutively active RIG-I (N-RIG) and/or IRF-
5. Ectopic expression of N-RIG and IRF-5 was detected in MEFs
24 hours after transfection by western blotting (Figure 7A) and
qRT-PCR (data not shown). As expected, we observed increased
expression of ISGs (e.g., Rsad2, Ifit1, and Oas1a) in WT MEFs
transfected with N-RIG compared to untransfected cells
(Figure 7B–D). Transfection of N-RIG alone in DKO cells
failed to induce these ISGs, suggesting that endogenous IRF-5 in
MEFs is not adequately expressed or activated to induce ISGs
after a MAVS-dependent signal; these results agree with prior
studies showing that the combined loss of IRF-3 and IRF-7 in
MEFs abolished the ISG response after WNV infection [22,27]. In
comparison, co-transfection of N-RIG and IRF-5 together but not
IRF-5 alone enhanced ISG induction in DKO and TKO MEFs.
Thus, MAVS-dependent induction of ISGs can occur through an
IRF-5-dependent yet IRF-3 and IRF-7-independent pathway.
Discussion
In the present study, we generated Irf32/26Irf52/26Irf72/2
TKO mice to establish that these three IRF family transcription
factors coordinately regulate IFN-b production and ISG expres-
sion in mDC. We found that antiviral gene induction was ablated
almost entirely in mDC from TKO or Mavs2/2 mice, suggesting a
dominant role for MAVS in initiating the antiviral response and
pointing to a novel signaling interaction between IRF-5 and the
RLR signaling pathway.
As TKO mice succumbed to WNV infection with similar
kinetics compared to Ifnar2/2 mice, we expected they would be
completely defective at producing type I IFN. Nonetheless, we
detected type I IFN activity in the serum of infected TKO mice,
suggesting that some cells must produce type I IFN by a pathway
that is independent of IRF-3, IRF-5, and IRF-7. Macrophages or
related cells (e.g., inflammatory monocytes) may be one source of
this residual type I IFN in vivo, as TKO macrophages cultured ex
vivo expressed Ifnb as well as a subset of ISGs in response to WNV
infection. Type I IFN induction in TKO macrophages could be
mediated in part by IRF-1, which regulates expression of antiviral
genes independently of type I IFN in the context of several other
viral infections [13,51,52]. Consistent with this, Irf12/2 macro-
phages supported enhanced WNV replication compared to WT
controls [40], and viral replication in TKO macrophages did not
phenocopy Ifnar2/2 cells. Nonetheless, IRF-1 was not sufficient to
induce the full complement of ISGs in macrophages, as Ifnb and
ISG expression in TKO macrophages was diminished and delayed
compared to WT cells. Furthermore, IFIT3 was not expressed in
TKO macrophages, although it was sustained in DKO cells [22].
It remains unclear whether the genes upregulated in TKO
macrophages were induced by IRF-1 directly, by another
transcription factor, or downstream of IFN-b production by these
cells.
We measured ISG induction in infected mDC to determine
whether a lack of antiviral effector gene expression explained the
failure of TKO mice and mDC to control WNV replication. In
our experiments, fewer than 15% of mDC were infected at
24 hours, even when a high MOI of 25 was used. Increasing the
MOI to 100 achieved only marginally higher rates of infection
(data not shown) and was not practical for the scale of the
microarray experiments. Sorting infected cells by flow cytometry
prior to transcriptional profiling analysis was not feasible as
infected cells must be permeabilized to detect intracellular WNV
antigens and recombinant WNV expressing green fluorescent
protein are attenuated and/or unstable [53–55]. In our micro-
array studies, uninfected cells likely contributed substantially to the
ISG expression signatures observed. Indeed, few genes were
induced in WNV-infected TKO or Mavs2/2 mDC, even though
these cells would be expected to upregulate genes associated with
cell stress, survival, and metabolism in response to replication by a
cytopathic virus. Some components of the unfolded protein
response, including Ddit3 and Gadd45a, were upregulated in
infected TKO mDC; additional genes likely were induced in
infected cells but may have been below the statistical cutoffs used
in our analysis due to dilution of the transcripts in a large pool of
mRNA from uninfected cells.
Viral infection induces the expression of ISGs both directly (by
IRF-3 after PAMP detection and PRR signaling) and indirectly (by
cells on a log2 scale, and are expressed as the mean 6 SEM. G. mDC from WT and Irf5
2/2 mice were infected at an MOI of 0.001 and viral replication
was measured by focus-forming assay. Data represent the mean 6 SEM of six independent experiments performed in triplicate. WT and Irf52/2 titers
were compared by two-way ANOVA and were not significantly different (P.0.05). The dotted line represents the limit of detection of the assay.
doi:10.1371/journal.ppat.1003118.g006
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IFN-b production and IFNAR signaling), the latter occurring in
both infected and uninfected cells. Given the large proportion of
uninfected cells, we would expect genes induced by IFNAR
signaling to predominate. Indeed, only a small subset of genes was
induced after WNV infection of Ifnar2/2 mDC (22 genes,
compared to 445 in WT mDC). This may reflect the relatively
low infection rates, an inherent inefficiency of IFNAR-indepen-
dent gene induction pathways, or viral countermeasures that
antagonize the type I IFN response in highly infected cells [56]. Of
the 22 genes induced in WNV-infected Ifnar2/2 mDC, several
(Ifnb, Cxcl10, Rsad2, Ifit1, and Ifit2) have direct or indirect antiviral
activity against WNV [13,24,41,42,57–59] and are induced
directly by IRF-3 [14,15]. Other genes induced in WNV-infected
Ifnar2/2 mDC included components of the unfolded protein
response, such as Ddit3 and Ppp1r15a. Ddit3 (CHOP) has been
shown to promote expression of Ppp1r15a (Gadd34) and Trib3 [60–
62], two IFN-independent induced genes detected in our
microarray analysis. While induction of these genes may represent
a response to the cellular stress caused by viral infection, the
unfolded protein response also constitutes a cellular defense that
limits replication of diverse viruses, including WNV [60,63,64].
DDIT3 inhibits WNV replication, and WNV may induce
expression of Ppp1r15a to reverse DDIT3-mediated translational
inhibition [60]. In contrast, PPP1R15A is required for IFN-b
production and contributes to controlling replication of chikungu-
nya virus [65].
Although global gene induction in response to WNV infection
has been reported previously [46–49,66,67], our results represent
the first such analysis in DCs, which are a sentinel cell type
coordinating the innate and adaptive antiviral immune responses,
as well as among the first cells infected following a mosquito bite
[8,68]. Some of the genes we identified in mDCs also were
detected in microarray analyses of WNV-infected MEFs [46],
human kidney epithelial cells [48], or human retinal pigmented
epithelium [47]. Induction of these genes (e.g., Rsad2, Ifit2, Isg15,
Isg20, and Stat1) thus does not depend on cell type-specific
transcription factors. Other WNV-induced genes, however, may
be specific to DCs or restricted cell types. As an example, the
chemokine Cxcl10 was one of the most highly induced genes in our
analysis, yet it was induced at much lower levels or not at all in
fibroblasts and epithelial cells [46–48]. CXCL10 contributes to
clearance of WNV infection from the CNS by recruiting effector T
cells, and is the dominant chemokine secreted by neurons after
WNV infection [57].
Only one of the 22 genes differentially expressed in Ifnar2/2
mDC, Ddit3, was induced in Mavs2/2 mDC, suggesting that the
IFN-independent induction signal is conveyed almost entirely by
MAVS. Since Mavs2/2 mDC failed to produce IFN-b, we surmise
Figure 7. WT, Irf32/26Irf72/2 DKO, and Irf32/26Irf52/26Irf72/2 TKO immortalized MEFs were transfected with plasmids expressing
myc-tagged IRF-5 or residues 1–229 of RIG-I (N-RIG) and analyzed at 24 hours after transfection by western blot (A) or qRT-PCR (B–
D). A. Transfected cell lysates were separated by SDS-PAGE and N-RIG or IRF-5 were detected with an anti-myc-tag antibody. Un: no transfection.
Expression of N-RIG and IRF-5 was decreased slightly upon co-transfection, likely secondary to promoter competition. B–D. Expression of the
indicated ISGs was measured from total RNA by qRT-PCR. Gene expression was normalized to Gapdh and is displayed as the fold increase compared
to untransfected cells on a log2 scale. Data represent the average of four samples from two independent experiments and are expressed as the mean
6 SEM. The co-transfection group was compared to transfection with the individual plasmids by two-way ANOVA for DKO and TKO groups; asterisks
indicate differences that are statistically significant (****, P,0.0001; ***, P,0.001; **, P,0.01; *, P,0.05).
doi:10.1371/journal.ppat.1003118.g007
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that both type I IFN-dependent and -independent pathways of
ISG induction are abrogated in these cells. This conclusion agrees
with earlier studies on induction of selected sets of genes in
Mavs2/2 mDC infected with WNV or rabies virus [27,69].
Although Mavs2/2 cells should retain TLR-mediated antiviral
gene induction pathways (which signal through TRIF and
MyD88), we observed almost no ISG induction in Mavs2/2
mDC after WNV infection. Thus, RLRs likely are the dominant
PRRs that sense WNV infection in mDC; these results are
consistent with the essentially intact antiviral responses reported in
WNV-infected Tlr32/2 and Myd882/2 mDC [26,28].
Although our microarray and qRT-PCR analyses identified 16
genes that were differentially expressed in WNV-infected Ifnar2/2
and DKO but not TKO mDC, when gene expression was
analyzed from WNV-infected DKO cells that were treated with an
antibody blocking type I IFN signaling, only Ifnb gene induction
was sustained. These data suggest that in the absence of IRF-3 and
IRF-7, IRF-5 is sufficient to induce IFN-b production in response
to WNV infection, but unlike IRF-3 [14,15], does not induce ISGs
directly (Figure 8). Although IRF-5 has been suggested to
promote IFN-independent expression of some ISGs including Pkr
and Isg20 in NDV-infected cells [38], IRF-3 may have contributed
to these responses. The observed anti-WNV response in DKO
mDC likely results from IRF-5-dependent IFN-b production, and
the uncontrolled viral replication in TKO mDC is secondary to a
lack of IFN-b and resultant absence of ISG induction. This model
suggests that cell types having ancillary pathways for IFN-b
induction (such as IRF-1 in macrophages) can mount antiviral
responses even in the absence of IRF-3, IRF-5, and IRF-7.
We did not anticipate that the Mavs2/2 and TKO mDC would
phenocopy one other with respect to ISG induction, since IRF-5
has not been previously implicated in the RLR signaling pathway
[35–37]. IRF-5 originally was described as an inducer of pro-
inflammatory cytokines (e.g., IL-6 and TNF-a) but subsequently
was suggested to contribute to the type I IFN antiviral response.
Irf52/2 mice have increased susceptibility to viral infections,
slightly reduced levels of type I IFN in serum, and more
significantly reduced levels of pro-inflammatory cytokines
[35,37]. IRF-5 expression and antiviral activity, however, appears
restricted to a limited set of cell types, including monocytes and
DCs [35,39,70]. Thus, a relative absence of IRF-5 expression in
fibroblasts and neurons may explain the observation that type I
IFN induction after WNV infection in these cell types is abolished
by the combined deletion of IRF-3 and IRF-7 [22]. However, the
ability of alternate IRFs to compensate for IRF-3 and IRF-7 in
fibroblasts also may depend on the particular viral stimulus, as
type I IFN production was essentially absent in DKO fibroblasts
infected with WNV, herpes simplex virus, vesicular stomatitis
virus, or encephalomyocarditis virus [19,22], but low-level
production of Ifnb and Ifna2 mRNA was sustained in DKO
fibroblasts infected with chikungunya virus [33]. IRF-5 preferen-
tially stimulates the IFN-b and IFN-a4 promoters, rather than
other IFN-a subtypes, which also suggests that it contributes to the
primary type I IFN response, prior to amplification via autocrine
and paracrine signaling [35]. The IFN-a subtypes induced in IRF-
5-expressing cells vary from those induced in IRF-7-expressing
cells, suggesting that the IRF expression patterns within a cell
modulate the breadth of the type I IFN response [70].
Although MAVS previously was known to induce IFN-b
production via IRF-3 and IRF-7, our experiments suggest that
RLR signaling also activates IRF-5 to induce IFN-b production in
mDC; the subcellular location where this occurs (e.g., mitochon-
drion) and through what signaling intermediates remains un-
known. A recent study suggested that activation of RLR signaling
acts to inhibit induction of inflammatory cytokines by IRF-5 [71];
although the net result was different, this study is consistent with
our observation of a functional interaction between IRF-5 and
MAVS and with a prior proteomic study demonstrating a physical
interaction between these two proteins [72]. Future studies will be
required to delineate the mechanistic and functional intermediates
that link and regulate the IRF-5 and RLR signaling pathways.
Materials and Methods
Viruses
The WNV-NY strain (3000.0259) was isolated in New York in
2000 and passaged once in C6/36 Aedes albopictus cells to generate
a virus stock that was used in all experiments except for the
microarray analysis [73,74]. For the microarray studies, mDCs
were infected in the Früh laboratory with the WNV New York
1999 strain that was propagated in C6/36 cells [75]. The
attenuated strain WNV-MAD was amplified in Vero cells and
has been previously described [23]. MNV strain MNV1.CW3 [76]
was propagated in RAW 264.7 cells (ATCC) and a concentrated
stock was prepared as previously described [77]. The SeV virus
strain Fushimi was propagated in chicken embryos and provided
by D. Lenschow and M. Holtzman (Washington University, St
Louis, MO).
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee at the Washington University School of Medicine
(Assurance Number: A3381-01). Dissections and footpad injec-
tions were performed under anesthesia that was induced and
maintained with ketamine hydrochloride and xylazine, and all
efforts were made to minimize suffering.
Mouse experiments
All mice used were on an inbred C57BL/6 background. WT
mice were commercially obtained (Jackson Laboratories).
Irf32/26Irf72/2 DKO, Irf52/2, and Ifnar2/2 mice have been
reported previously [22,31,36]. Irf32/26Irf52/26Irf72/2 TKO
mice were generated by crossing DKO and Irf52/2 mice. Irf52/2
and TKO mice were genotyped for a mutation in the Dock2 gene,
which can arise spontaneously in some Irf52/2 mice [78]; none of
the TKO mice had homozygous mutations in Dock2. Mavs2/2
mice were generated directly from C57BL/6 embryonic stem cells
[34]. All deficient mice were bred in the animal facilities of the
Washington University School of Medicine and genotyped prior to
experimentation. For WNV infections, 102 PFU was diluted in
Hank’s Balanced Salt Solution supplemented with 1% heat-
inactivated fetal bovine serum and 8 to 12 week-old mice were
inoculated by footpad injection in a volume of 50 ml. For MNV
infections, 7 to 8 week-old mice were inoculated orally with
36107 PFU in 25 ml of PBS and monitored for survival for 21
days.
Measurement of viral burden
To monitor viral spread in vivo, mice were infected with
102 PFU of virus and sacrificed at 2 days after infection (WNV-
NY) or 6 days after infection (WNV-MAD). After extensive
perfusion with PBS, organs were harvested, weighed, homoge-
nized and virus was titered by plaque assay on BHK21-15 cells
[74]. Viral burden in serum and inguinal lymph node was
measured using fluorogenic qRT-PCR using primers and probes
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Figure 8. Model of Type I IFN and ISG induction in mDC. WNV infection is sensed by PRR from the RLR family (RIG-I and MDA5, green) or TLR
family (TLR3 and TLR7, yellow and orange). PRR signal through their respective adaptor molecules (MAVS, TRIF, MyD88), which activates cellular
kinases (TBK1, IKKe, TRAF6, IRAK1). Phosphorylation of IRF-3, IRF-5, and IRF-7 (blue) induces nuclear localization, and in concert with other
transcription factors (e.g., NF-kB), results in induced expression of Ifnb and ISGs. IRF-3, IRF-5, and IRF-7 are each sufficient to induce expression of IFN-
b (red), which can signal through IFNAR to activate expression of hundreds of ISGs (pink). Some ISGs, including Ifna, Oas1a, and Pkr, are dependent
strictly upon IFN signaling for their induction. Others, including Ifit1, Ifit2, Rsad2, and Cxcl10, can be induced directly by IRF-3, although IRF-5
apparently is not sufficient to induce these genes independently of IFN signaling. In addition to being activated by TLR7 signaling through MyD88,
IRF-5 is activated by MAVS through an uncharacterized pathway.
doi:10.1371/journal.ppat.1003118.g008
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to WNV-NY or WNV-MAD envelope gene sequences (Table
S4). Viral RNA in the lymph node was normalized to Gapdh levels
in tissue samples. Viral RNA from serum was isolated using a Viral
RNA Mini Kit (Qiagen). Total RNA from lymph nodes was
extracted using the E.Z.N.A. total RNA kit (Omega Bio-tek) and
DNase-treated to remove genomic DNA. Quantitative RT-PCR
was performed using One-Step RT-PCR Master Mix and a 7500
Fast Real-Time PCR System (Applied Biosystems).
Quantification of type I IFN activity
Levels of biologically active type I IFN in serum were
determined using an encephalomyocarditis virus L929 cytopathic
effect bioassay as described [79]. The amount of type I IFN per ml
of serum was calculated from a standard curve using IFN-b (PBL
InterferonSource) and adjusted for the background inhibitory
activity of naı̈ve serum (approximately 0.1 IU/ml). The inhibitory
activity of naı̈ve serum was type I IFN-independent because it was
acid labile but resistant to treatment with heat (56uC) or the
IFNAR-blocking antibody MAR1-5A3 [17,50].
Primary cell infections
Macrophage and mDC cultures were generated as described
previously [79]. Briefly, bone marrow was isolated from WT, DKO,
TKO, Irf52/2, or Ifnar2/2 mice and cultured for seven days in the
presence of 40 ng/ml M-CSF (PeproTech) to generate macro-
phages or with 20 ng/ml GM-CSF and 20 ng/ml IL-4 (PeproTech)
to produce mDC. Multi-step virus growth analysis was performed
after infection at a MOI of 0.01 for macrophages or 0.001 for
mDCs. Supernatants were titered by focus-forming assay on Vero
cells using humanized E16 anti-WNV MAb as the detection
antibody [80], horseradish peroxidase conjugated anti-human IgG
(Sigma), and True Blue Peroxidase Substrate (KPL). For western
blotting, cells were infected at an MOI of 1. For measurement of
ISG induction by qRT-PCR, cells were infected at an MOI of 0.1.
To block signaling by type I IFN, DKO cells were treated with
25 mg/ml of the IFNAR-blocking MAb MAR1-5A3 for one hour
prior to infection. A non-binding MAb against human IFN-c
receptor (GiR-208) was used as an isotype control [50].
Microarray analysis of mDCs
Bone marrow cells were cultured in RPMI supplemented with
10% fetal bovine serum, penicillin/streptomycin, L-glutamine,
non-essential amino acids, 55 mM b-mercaptoethanol and 20 ng/
ml recombinant mouse GM-CSF (eBioscience) for six days in non-
tissue culture treated plates. GM-CSF was replenished after two
days and non-adherent cells were sub-cultured after 4 days. Sub-
cultured cells were infected at an MOI of 25 with WNV-NY. Total
RNA was harvested at 0, 6, 12, and 24 hours post-infection with
an RNeasy Mini Kit (Qiagen). RNA was treated with DNase prior
to cDNA generation. Gene expression was assayed on Illumina
microarray chips. Microarray datasets were processed by quantile
normalization and annotated using the illuminaMousev2.db R
package version 1.10.0. Data were assessed by linear modeling
with the limma package [81]. Differentially expressed genes were
identified as those with at least a 1.5-fold change as compared to
controls and a P-value,0.05 without correction for false discovery.
WNV-infected samples were first compared with mock-infected
controls. Microarray data have been deposited in GeoArchive,
series number GSE42232.
Transfection and ectopic expression
MEFs prepared from WT, DKO, or TKO mice were
immortalized after transfection with the plasmid pSV2, which
encodes for the large T antigen of SV40. MEFs were transfected
using Lipofectamine 2000 (Invitrogen) with plasmids expressing
myc-tagged forms of murine IRF-5 (Origene) or residues 1–229 of
human RIG-I (N-RIG) [82]. Cells were lysed 24 hours post-
transfection and analyzed by qRT-PCR and western blotting.
Western blotting
Macrophages and mDC were lysed in RIPA buffer (10 mM
Tris, 150 mM NaCl, 0.02% sodium azide, 1% sodium deoxycho-
late, 1% Triton X-100, 0.1% SDS, pH 7.4), with protease
inhibitors (Sigma). Samples (20 mg) were resolved by electropho-
resis on 10% SDS-polyacrylamide gels. MEFs were lysed in RIPA
buffer and lysates were separated by electrophoresis on 4–12%
SDS-polyacrylamide gels. Following transfer of proteins, mem-
branes were blocked with 5% non-fat dried milk and probed with
the following panel of primary antibodies: rabbit anti-IFIT2 and -
IFIT3 (provided by Dr. G. Sen, [83]); rabbit anti-RIG-I and anti-
MDA5 (IBL); mouse anti-tubulin (Sigma); rabbit anti-GAPDH
(Santa Cruz); rabbit anti-STAT1 (Cell Signaling); goat-anti WNV
NS3 (R&D Systems); mouse anti-myc (Santa Cruz). Western blots
were incubated with peroxidase-conjugated secondary antibodies
(Jackson Immunoresearch and Sigma) and visualized using ECL
reagents (Amersham Biosciences and Pierce).
Measurement of ISG expression by qRT-PCR
mDCs were treated for 24 hours with 500 IU/ml of IFN-b (PBL
Interferon Source), 50 mg/ml of poly(I:C) (InvivoGen), or 5 mg/ml
of LPS (List Biological Laboratories). Macrophages and mDC were
infected with WNV-NY at an MOI 0.1 for 24 hours. MEFs were
harvested 24 hours after transfection. Total RNA was extracted
using the E.Z.N.A. total RNA kit (Omega Bio-tek) or RNeasy kit
(Qiagen) and treated with DNase. Fluorogenic qRT-PCR was
performed using One-Step RT-PCR Master Mix and a 7500 Fast
Real-Time PCR System (Applied Biosystems) with the indicated
Taqman primers and probes (Table S4). Gene induction was
normalized to Gapdh levels and expressed on a log2 scale as fold
increase over mock according to the DDCt method [84].
Statistical analysis
Data were analyzed with GraphPad Prism software. Viral
burdens were compared using the Mann-Whitney test. Serum type
I IFN levels, viral growth curves and qRT-PCR were compared
using a 2-way ANOVA. Kaplan-Meier survival curves were
analyzed by the log rank test and mean times to death were
compared by Student’s T-test.
Supporting Information
Figure S1 Genotyping of TKO mice. DNA from the tails of
the indicated mice was amplified by PCR using primers specific for
IRF-3, IRF-5, or IRF-7 and separated by agarose gel electropho-
resis. The band sizes confirmed the genotypes of the knockout
mice.
(TIF)
Table S1 Gene induction in WNV-NY infected mDC. All
genes (445) for which expression level in at least one genotype was
$1.5-fold changed at 24 hours after WNV infection (P,0.05,
without correction for false discovery). Values represent the mean of
three independent samples for each genotype. ‘‘Fold change’’ refers
to the relative fold change of expression in WNV-infected mDC
compared with mock-infected controls of the same genotype. DKO:
Irf32/26Irf72/2; TKO: Irf32/26Irf 52/26Irf72/2.
(DOCX)
IRF-3, -5, and -7 Mediate the IFN Response in mDC
PLOS Pathogens | www.plospathogens.org 13 January 2013 | Volume 9 | Issue 1 | e1003118
Table S2 IFN-independent gene induction. Genes are
shown for which expression level in Ifnar2/2 mDC was $1.5-fold
changed at 24 hours after WNV infection (P,0.05, without
correction for false discovery). Values represent the mean of three
independent samples for each genotype. ‘‘Fold change’’ refers to
the relative fold change of expression in WNV-infected mDC
compared with mock-infected controls of the same genotype.
DKO: Irf32/26Irf72/2; TKO: Irf32/26Irf 52/26Irf72/2.
(DOCX)
Table S3 Genes induced in IFNAR and DKO, but not
TKO mDC. Genes are shown for which expression level in
Ifnar2/2 and DKO mDC was $1.5-fold changed at 24 hours after
WNV infection (P,0.05), but which fell short of these cutoffs in
TKO cells. Values represent the mean of three independent
samples for each genotype. ‘‘Fold change’’ refers to the relative
fold change of expression in WNV-infected mDC compared with
mock-infected controls of the same genotype. DKO:
Irf32/26Irf72/2; TKO: Irf32/26Irf 52/26Irf72/2.
(DOCX)
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